trending Market Intelligence /marketintelligence/en/news-insights/trending/MFCXP-yvSG_Gs2HqnVrTww2 content esgSubNav
In This List

Obalon Therapeutics prices $3M common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Obalon Therapeutics prices $3M common stock offering

San Diego-based Obalon Therapeutics Inc. plans to raise about $3 million from a registered direct offering of common stock.

The company entered into definitive agreements with investors to sell 5 million common shares priced at 60 cents apiece.

The medical-device company, which is focused on weight loss technologies, plans to use the net proceeds for general corporate purposes, working capital, product development, capital expenditures and for other business opportunities.

The offering is expected to close by May 28.

Obalon Therapeutics retained Alliance Global Partners as a financial adviser in connection with the offering.